The Current Ratio as of November 2024 (TTM) for Alterity Therapeutics Limited (PRNAF) is 3.54

According to Alterity Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 3.54. This represents a change of -16.03% compared to the average of 4.22 of the last 4 quarters.

Alterity Therapeutics Limited (PRNAF) Historical Current Ratio (quarterly & annually)

How has PRNAF Current Ratio performed in the past?

The mean historical Current Ratio of Alterity Therapeutics Limited over the last ten years is 9.11. The current 3.54 Current Ratio has changed 3.79% with respect to the historical average. Over the past ten years (40 quarters), PRNAF's Current Ratio was at its highest in in the September 2015 quarter at 16.39. The Current Ratio was at its lowest in in the March 2024 quarter at 3.54.

Alterity Therapeutics Limited (PRNAF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alterity Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alterity Therapeutics Limited (PRNAF) Average Current Ratio

How has PRNAF Current Ratio performed in the past?

The current Current Ratio of Alterity Therapeutics Limited (PRNAF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alterity Therapeutics Limited (PRNAF) Current Ratio vs. Peers

How is PRNAF’s Current Ratio compared to its peers?

Alterity Therapeutics Limited’s Current Ratio is greater than Genprex, Inc. (1.95), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), less than Greenwich LifeSciences, Inc. (5.34), greater than Cognition Therapeutics, Inc. (3.07), less than Gracell Biotechnologies Inc. (7.73), less than Galectin Therapeutics Inc. (0), greater than Northwest Biotherapeutics, Inc. (1.87), greater than CEL-SCI Corporation (0.09), greater than Tonix Pharmaceuticals Holding Corp. (0.64), greater than Jaguar Health, Inc. (1.15), greater than Acasti Pharma Inc. (2.10), less than Diffusion Pharmaceuticals Inc. (7.86), less than iBio, Inc. (10.96), less than Vaxart, Inc. (4.08), less than Novavax, Inc. (4.54), greater than Ocugen, Inc. (1.04), greater than CohBar, Inc. (1.04), less than Rain Therapeutics Inc. (15.69), less than Viking Therapeutics, Inc. (5.58), less than TG Therapeutics, Inc. (36.47), less than X4 Pharmaceuticals, Inc. (3.58), less than PDS Biotechnology Corporation (6.07), less than Madrigal Pharmaceuticals, Inc. (3.84), less than null (5.98),

Build a custom stock screener for Alterity Therapeutics Limited (PRNAF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alterity Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alterity Therapeutics Limited (PRNAF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alterity Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.